We are offering free rapid genetic tests to screen for Alzheimer's disease risk
You should consider a free rapid test if you:
Your personal risk of developing Alzheimer's is hidden by your unique combination of DNA. Through a process called genotyping, we can reveal what your DNA says about your Alzheimer's risk, specifically by looking at the APOE gene.
- have a family history of Alzheimer's disease
- are interested in participating in clinical research studies
- notice worsening memory issues
Your personal risk of developing Alzheimer's is hidden by your unique combination of DNA. Through a process called genotyping, we can reveal what your DNA says about your Alzheimer's risk, specifically by looking at the APOE gene.
What is the APOE gene?

The APOE gene is associated with genetic risk of developing Alzheimer's. Every person has two copies of the APOE gene (one from your mother and one from your father). The APOE gene occurs most commonly in three different variants: E2, E3, and E4. These variants influence your risk of Alzheimer's disease.
How do I get tested?
After making an appointment with NeuroScience Research Center by calling at 330-244-2542, you will arrive at our office and be greeted by one of our staff. A staff member will perform a cheek swab by brushing the inside of your cheek with a cotton swab to collect a sample. This process is completely painless. Your sample will then be placed in DNA analyzer that performs PCR (similar to a COVID-19 test). Although your results will be ready within 70 minutes, you can abstain from hearing them if you wish.
|
What happens to my sample/data?
Your privacy and safety is our first priority, so your identity and any personal health information collected at the site will remain confidential and only used to confirm your eligibility for ongoing or future studies, if you so choose to participate in them. Additionally, a federal law called the Genetic Information Nondiscrimination Act (GINA) protects you from discrimination in searching for employment or health insurance coverage on the basis of genetic information.